REACTION BIOLOGY Trademark
Trademark Overview
On Thursday, July 10, 2025, a trademark application was filed for REACTION BIOLOGY with the United States Patent and Trademark Office. The USPTO has given the REACTION BIOLOGY trademark a serial number of 99276246. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, December 19, 2025. This trademark is owned by Reaction Biology Corporation. The REACTION BIOLOGY trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:
Laboratory research and medical contract research services relating to molecular sciences; drug discovery services; pharmaceutical research and development; therapeutic product research and development services; providing information regarding drug discovery, pharmaceuticals research and development, and therapeutics product research and development
Enzymes for drug discovery for scientific and research purposes; enzymes for pharmaceutical and therapeutic research and scientific development purposes
General Information
| Serial Number | 99276246 |
| Word Mark | REACTION BIOLOGY |
| Filing Date | Thursday, July 10, 2025 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, December 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Laboratory research and medical contract research services relating to molecular sciences; drug discovery services; pharmaceutical research and development; therapeutic product research and development services; providing information regarding drug discovery, pharmaceuticals research and development, and therapeutics product research and development |
| NOT AVAILABLE | BIOLOGY |
| Goods and Services | Enzymes for drug discovery for scientific and research purposes; enzymes for pharmaceutical and therapeutic research and scientific development purposes |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 19, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | Monday, March 3, 2003 |
| First Use In Commerce Date | Monday, March 3, 2003 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, July 10, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, March 3, 2003 |
| First Use In Commerce Date | Monday, March 3, 2003 |
Trademark Owner History
| Party Name | Reaction Biology Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Malvern, PA 19355 |
Trademark Events
| Event Date | Event Description |
| Thursday, July 10, 2025 | NEW APPLICATION ENTERED |
| Thursday, July 10, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 10, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 29, 2025 | ASSIGNED TO EXAMINER |
| Thursday, December 4, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, December 4, 2025 | NON-FINAL ACTION E-MAILED |
| Thursday, December 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |